PortalPublikationenDyskinesia in multiple system atrophy and progressive supran...

Dyskinesia in multiple system atrophy and progressive supranuclear palsy

Standard

Dyskinesia in multiple system atrophy and progressive supranuclear palsy. / Jost, Wolfgang H; Lingor, Paul; Tönges, Lars; Schwarz, Johannes; Buhmann, Carsten; Kassubek, Jan; Schrag, Anette.

in: J NEURAL TRANSM, Jahrgang 126, Nr. 7, 07.2019, S. 925-932.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Jost, WH, Lingor, P, Tönges, L, Schwarz, J, Buhmann, C, Kassubek, J & Schrag, A 2019, 'Dyskinesia in multiple system atrophy and progressive supranuclear palsy', J NEURAL TRANSM, Jg. 126, Nr. 7, S. 925-932. https://doi.org/10.1007/s00702-019-02012-0

APA

Jost, W. H., Lingor, P., Tönges, L., Schwarz, J., Buhmann, C., Kassubek, J., & Schrag, A. (2019). Dyskinesia in multiple system atrophy and progressive supranuclear palsy. J NEURAL TRANSM, 126(7), 925-932. https://doi.org/10.1007/s00702-019-02012-0

Vancouver

Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J et al. Dyskinesia in multiple system atrophy and progressive supranuclear palsy. J NEURAL TRANSM. 2019 Jul;126(7):925-932. https://doi.org/10.1007/s00702-019-02012-0

Bibtex

@article{14efeb039c5942d283c2f8e0c1ef4114,
title = "Dyskinesia in multiple system atrophy and progressive supranuclear palsy",
abstract = "In the differential diagnosis of Parkinson syndromes, the response to L-Dopa is an essential criterion for the diagnosis of idiopathic Parkinson's syndrome (IPS), and the presence of L-Dopa-induced dyskinesia (LID) is considered a supportive criterion. This implies that in the presence of LID an atypical Parkinson-syndrome (APS) is unlikely. However, dyskinesia, and in particular LID, can also be present in APS such as MSA and PSP, although less frequently, and with varying clinical appearance. We conclude that whilst presence of dyskinesia provides support for a diagnosis of IPD, they do not allow reliable differentiation from APS.",
keywords = "Journal Article, Review",
author = "Jost, {Wolfgang H} and Paul Lingor and Lars T{\"o}nges and Johannes Schwarz and Carsten Buhmann and Jan Kassubek and Anette Schrag",
year = "2019",
month = jul,
doi = "10.1007/s00702-019-02012-0",
language = "English",
volume = "126",
pages = "925--932",
journal = "J NEURAL TRANSM",
issn = "0300-9564",
publisher = "Springer",
number = "7",

}

RIS

TY - JOUR

T1 - Dyskinesia in multiple system atrophy and progressive supranuclear palsy

AU - Jost, Wolfgang H

AU - Lingor, Paul

AU - Tönges, Lars

AU - Schwarz, Johannes

AU - Buhmann, Carsten

AU - Kassubek, Jan

AU - Schrag, Anette

PY - 2019/7

Y1 - 2019/7

N2 - In the differential diagnosis of Parkinson syndromes, the response to L-Dopa is an essential criterion for the diagnosis of idiopathic Parkinson's syndrome (IPS), and the presence of L-Dopa-induced dyskinesia (LID) is considered a supportive criterion. This implies that in the presence of LID an atypical Parkinson-syndrome (APS) is unlikely. However, dyskinesia, and in particular LID, can also be present in APS such as MSA and PSP, although less frequently, and with varying clinical appearance. We conclude that whilst presence of dyskinesia provides support for a diagnosis of IPD, they do not allow reliable differentiation from APS.

AB - In the differential diagnosis of Parkinson syndromes, the response to L-Dopa is an essential criterion for the diagnosis of idiopathic Parkinson's syndrome (IPS), and the presence of L-Dopa-induced dyskinesia (LID) is considered a supportive criterion. This implies that in the presence of LID an atypical Parkinson-syndrome (APS) is unlikely. However, dyskinesia, and in particular LID, can also be present in APS such as MSA and PSP, although less frequently, and with varying clinical appearance. We conclude that whilst presence of dyskinesia provides support for a diagnosis of IPD, they do not allow reliable differentiation from APS.

KW - Journal Article

KW - Review

U2 - 10.1007/s00702-019-02012-0

DO - 10.1007/s00702-019-02012-0

M3 - SCORING: Review article

C2 - 31087195

VL - 126

SP - 925

EP - 932

JO - J NEURAL TRANSM

JF - J NEURAL TRANSM

SN - 0300-9564

IS - 7

ER -